Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches.
In the first article of this pair (page 77), Drs Weir and Bakris discussed a physiologic approach to management of diabetic hypertensive patients. In this article, they discuss the latest findings regarding use of angiotensin-converting enzyme inhibitors and calcium channel blockers along with glycemic control and reduced protein intake.
Weir
M R
MR
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201-1595.
Bakris
G L
GL
D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D012079:Renal Circulation / Q000187:drug effects; D012306:Risk
D000959:Antihypertensive Agents